English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 111 | Tables: 118 | Pharma & Healthcare
The global iPSC Therapy market was valued at US$ 89.67 million in 2025 and is anticipated to reach US$ 185 million by 2032, at a CAGR of 11.3% from 2026 to 2032.
iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine technology centered on induced pluripotent stem cells. In this approach, somatic cells such as skin or blood cells are reprogrammed by specific transcription factors to revert to a pluripotent state capable of differentiating into multiple cell types. These iPSCs can then be guided to develop into functional cells such as neurons, cardiomyocytes, retinal cells, or immune cells, which are used to replace or repair damaged tissues. iPSC therapy combines the pluripotency of embryonic stem cells with controllable cell sourcing, thereby avoiding major ethical concerns while enabling both personalized and standardized cell-based therapies. The technology shows significant potential in treating neurodegenerative diseases, cardiovascular disorders, ophthalmic conditions, cancer immunotherapy, and rare diseases. With continuous advances in cellular reprogramming, gene editing, and cell culture technologies, iPSC therapy is gradually transitioning from laboratory research to clinical applications and is becoming a key pillar of regenerative medicine and precision healthcare.
The market for iPSC therapy is driven by rapid advances in regenerative medicine and precision healthcare. The growing prevalence of chronic diseases, neurodegenerative disorders, and rare diseases highlights the limitations of conventional drug therapies in tissue repair and functional recovery, creating demand for cell-based treatments. iPSC technology provides a stable and expandable source of cells, supporting tissue regeneration, immune therapy, and disease modeling. Advances in gene editing and automated cell culture technologies are improving the safety, controllability, and scalability of cell therapy products. In addition, many governments worldwide are actively promoting the development of regenerative medicine through research funding, supportive policies, and industry collaboration, creating favorable conditions for the commercialization of iPSC-based therapies.
Despite its strong potential, iPSC therapy faces several challenges. The processes of cellular reprogramming and differentiation are complex and require strict control of culture conditions, quality assurance systems, and manufacturing standards. Potential risks such as tumorigenicity, immune rejection, and uncertainties regarding long-term therapeutic outcomes remain key concerns in clinical development. Regulatory authorities maintain rigorous approval procedures for cell-based therapies, resulting in long development timelines and high costs. In addition, supply chains for cell preparation, storage, and transportation are still evolving, which may affect the large-scale industrialization of the technology.
Downstream demand mainly comes from hospitals, biotechnology companies, and research institutions. As personalized medicine gains traction, demand for cell therapies targeting neurological disorders, cardiovascular diseases, and ophthalmic conditions continues to increase. iPSC-derived cells are also widely used in disease modeling, drug discovery, and toxicity testing, providing valuable platforms for pharmaceutical research. Healthcare providers and biopharmaceutical companies are increasingly exploring the therapeutic potential of cell-based treatments for complex diseases, driving continued growth in clinical research and industry partnerships. As manufacturing technologies mature and standardization improves, demand for iPSC therapy in both clinical treatment and drug development is expected to expand further.
The upstream segment of the iPSC therapy industry primarily includes cell culture media, growth factors, gene reprogramming vectors, and cell culture consumables. High-quality culture media and growth factors provide the necessary microenvironment for cell proliferation and differentiation and are essential components of cell production. Gene reprogramming tools, often based on viral or non-viral vector technologies, are used to introduce transcription factors into somatic cells to induce pluripotency. The production process also requires a large number of high-standard laboratory consumables such as culture dishes, flasks, and sterile filtration systems to maintain stable manufacturing conditions and consistent cell quality. With ongoing advancements in cell manufacturing technologies, automated culture equipment and advanced biomaterials are becoming increasingly important upstream components, supporting the technological progress of the entire cell therapy industry.
This report delivers a comprehensive overview of the global iPSC Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding iPSC Therapy. The iPSC Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global iPSC Therapy market comprehensively. Regional market sizes by Type, by Application, by End User, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist iPSC Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Fujifilm
Ncardia
Sumitomo Dainippon Pharma
Astellas Pharma Inc
Fate Therapeutics, Inc
Pluricell Biotech
Cell Inspire Biotechnology
ReproCELL
Thermo Fisher Scientific
Sartorius
Bio-techne
Segment by Type
Human iPSCs
Mouse iPSCs
Segment by End User
Hospitals
Biotech Firms
Research Institutes
Segment by Cell Type
Neural Cells
Cardiac Cells
Retinal Cells
Immune Cells
Segment by Application
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End User, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for iPSC Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global iPSC Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Human iPSCs
1.2.3 Mouse iPSCs
1.3 Market by End User
1.3.1 Global iPSC Therapy Market Size Growth Rate by End User: 2021 vs 2025 vs 2032
1.3.2 Hospitals
1.3.3 Biotech Firms
1.3.4 Research Institutes
1.4 Market by Cell Type
1.4.1 Global iPSC Therapy Market Size Growth Rate by Cell Type: 2021 vs 2025 vs 2032
1.4.2 Neural Cells
1.4.3 Cardiac Cells
1.4.4 Retinal Cells
1.4.5 Immune Cells
1.5 Market by Application
1.5.1 Global iPSC Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Academic Research
1.5.3 Drug Development and Discovery
1.5.4 Toxicity Screening
1.5.5 Regenerative Medicine
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global iPSC Therapy Market Perspective (2021–2032)
2.2 Global iPSC Therapy Growth Trends by Region
2.2.1 Global iPSC Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 iPSC Therapy Historic Market Size by Region (2021–2026)
2.2.3 iPSC Therapy Forecasted Market Size by Region (2027–2032)
2.3 iPSC Therapy Market Dynamics
2.3.1 iPSC Therapy Industry Trends
2.3.2 iPSC Therapy Market Drivers
2.3.3 iPSC Therapy Market Challenges
2.3.4 iPSC Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top iPSC Therapy Players by Revenue
3.1.1 Global Top iPSC Therapy Players by Revenue (2021–2026)
3.1.2 Global iPSC Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top iPSC Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by iPSC Therapy Revenue
3.4 Global iPSC Therapy Market Concentration Ratio
3.4.1 Global iPSC Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by iPSC Therapy Revenue in 2025
3.5 Global Key Players of iPSC Therapy Head Offices and Areas Served
3.6 Global Key Players of iPSC Therapy, Products and Applications
3.7 Global Key Players of iPSC Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 iPSC Therapy Breakdown Data by Type
4.1 Global iPSC Therapy Historic Market Size by Type (2021–2026)
4.2 Global iPSC Therapy Forecasted Market Size by Type (2027–2032)
5 iPSC Therapy Breakdown Data by Application
5.1 Global iPSC Therapy Historic Market Size by Application (2021–2026)
5.2 Global iPSC Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America iPSC Therapy Market Size (2021–2032)
6.2 North America iPSC Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America iPSC Therapy Market Size by Country (2021–2026)
6.4 North America iPSC Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe iPSC Therapy Market Size (2021–2032)
7.2 Europe iPSC Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe iPSC Therapy Market Size by Country (2021–2026)
7.4 Europe iPSC Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific iPSC Therapy Market Size (2021–2032)
8.2 Asia-Pacific iPSC Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific iPSC Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific iPSC Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America iPSC Therapy Market Size (2021–2032)
9.2 Latin America iPSC Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America iPSC Therapy Market Size by Country (2021–2026)
9.4 Latin America iPSC Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa iPSC Therapy Market Size (2021–2032)
10.2 Middle East & Africa iPSC Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa iPSC Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa iPSC Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fujifilm
11.1.1 Fujifilm Company Details
11.1.2 Fujifilm Business Overview
11.1.3 Fujifilm iPSC Therapy Introduction
11.1.4 Fujifilm Revenue in iPSC Therapy Business (2021–2026)
11.1.5 Fujifilm Recent Development
11.2 Ncardia
11.2.1 Ncardia Company Details
11.2.2 Ncardia Business Overview
11.2.3 Ncardia iPSC Therapy Introduction
11.2.4 Ncardia Revenue in iPSC Therapy Business (2021–2026)
11.2.5 Ncardia Recent Development
11.3 Sumitomo Dainippon Pharma
11.3.1 Sumitomo Dainippon Pharma Company Details
11.3.2 Sumitomo Dainippon Pharma Business Overview
11.3.3 Sumitomo Dainippon Pharma iPSC Therapy Introduction
11.3.4 Sumitomo Dainippon Pharma Revenue in iPSC Therapy Business (2021–2026)
11.3.5 Sumitomo Dainippon Pharma Recent Development
11.4 Astellas Pharma Inc
11.4.1 Astellas Pharma Inc Company Details
11.4.2 Astellas Pharma Inc Business Overview
11.4.3 Astellas Pharma Inc iPSC Therapy Introduction
11.4.4 Astellas Pharma Inc Revenue in iPSC Therapy Business (2021–2026)
11.4.5 Astellas Pharma Inc Recent Development
11.5 Fate Therapeutics, Inc
11.5.1 Fate Therapeutics, Inc Company Details
11.5.2 Fate Therapeutics, Inc Business Overview
11.5.3 Fate Therapeutics, Inc iPSC Therapy Introduction
11.5.4 Fate Therapeutics, Inc Revenue in iPSC Therapy Business (2021–2026)
11.5.5 Fate Therapeutics, Inc Recent Development
11.6 Pluricell Biotech
11.6.1 Pluricell Biotech Company Details
11.6.2 Pluricell Biotech Business Overview
11.6.3 Pluricell Biotech iPSC Therapy Introduction
11.6.4 Pluricell Biotech Revenue in iPSC Therapy Business (2021–2026)
11.6.5 Pluricell Biotech Recent Development
11.7 Cell Inspire Biotechnology
11.7.1 Cell Inspire Biotechnology Company Details
11.7.2 Cell Inspire Biotechnology Business Overview
11.7.3 Cell Inspire Biotechnology iPSC Therapy Introduction
11.7.4 Cell Inspire Biotechnology Revenue in iPSC Therapy Business (2021–2026)
11.7.5 Cell Inspire Biotechnology Recent Development
11.8 ReproCELL
11.8.1 ReproCELL Company Details
11.8.2 ReproCELL Business Overview
11.8.3 ReproCELL iPSC Therapy Introduction
11.8.4 ReproCELL Revenue in iPSC Therapy Business (2021–2026)
11.8.5 ReproCELL Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific iPSC Therapy Introduction
11.9.4 Thermo Fisher Scientific Revenue in iPSC Therapy Business (2021–2026)
11.9.5 Thermo Fisher Scientific Recent Development
11.10 Sartorius
11.10.1 Sartorius Company Details
11.10.2 Sartorius Business Overview
11.10.3 Sartorius iPSC Therapy Introduction
11.10.4 Sartorius Revenue in iPSC Therapy Business (2021–2026)
11.10.5 Sartorius Recent Development
11.11 Bio-techne
11.11.1 Bio-techne Company Details
11.11.2 Bio-techne Business Overview
11.11.3 Bio-techne iPSC Therapy Introduction
11.11.4 Bio-techne Revenue in iPSC Therapy Business (2021–2026)
11.11.5 Bio-techne Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global iPSC Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Human iPSCs
Table 3. Key Players of Mouse iPSCs
Table 4. Global iPSC Therapy Market Size Growth Rate by End User (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Hospitals
Table 6. Key Players of Biotech Firms
Table 7. Key Players of Research Institutes
Table 8. Global iPSC Therapy Market Size Growth Rate by Cell Type (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of Neural Cells
Table 10. Key Players of Cardiac Cells
Table 11. Key Players of Retinal Cells
Table 12. Key Players of Immune Cells
Table 13. Global iPSC Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global iPSC Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 15. Global iPSC Therapy Market Size by Region (US$ Million), 2021–2026
Table 16. Global iPSC Therapy Market Share by Region (2021–2026)
Table 17. Global iPSC Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 18. Global iPSC Therapy Market Share by Region (2027–2032)
Table 19. iPSC Therapy Market Trends
Table 20. iPSC Therapy Market Drivers
Table 21. iPSC Therapy Market Challenges
Table 22. iPSC Therapy Market Restraints
Table 23. Global iPSC Therapy Revenue by Players (US$ Million), 2021–2026
Table 24. Global iPSC Therapy Market Share by Players (2021–2026)
Table 25. Global Top iPSC Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on iPSC Therapy Revenue, 2025
Table 26. Ranking of Global Top iPSC Therapy Companies by Revenue (US$ Million) in 2025
Table 27. Global 5 Largest Players Market Share by iPSC Therapy Revenue (CR5 and HHI), 2021–2026
Table 28. Global Key Players of iPSC Therapy, Headquarters and Area Served
Table 29. Global Key Players of iPSC Therapy, Products and Applications
Table 30. Global Key Players of iPSC Therapy, Date of General Availability (GA)
Table 31. Mergers and Acquisitions, Expansion Plans
Table 32. Global iPSC Therapy Market Size by Type (US$ Million), 2021–2026
Table 33. Global iPSC Therapy Revenue Market Share by Type (2021–2026)
Table 34. Global iPSC Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 35. Global iPSC Therapy Revenue Market Share by Type (2027–2032)
Table 36. Global iPSC Therapy Market Size by Application (US$ Million), 2021–2026
Table 37. Global iPSC Therapy Revenue Market Share by Application (2021–2026)
Table 38. Global iPSC Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 39. Global iPSC Therapy Revenue Market Share by Application (2027–2032)
Table 40. North America iPSC Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. North America iPSC Therapy Market Size by Country (US$ Million), 2021–2026
Table 42. North America iPSC Therapy Market Size by Country (US$ Million), 2027–2032
Table 43. Europe iPSC Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Europe iPSC Therapy Market Size by Country (US$ Million), 2021–2026
Table 45. Europe iPSC Therapy Market Size by Country (US$ Million), 2027–2032
Table 46. Asia-Pacific iPSC Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 47. Asia-Pacific iPSC Therapy Market Size by Region (US$ Million), 2021–2026
Table 48. Asia-Pacific iPSC Therapy Market Size by Region (US$ Million), 2027–2032
Table 49. Latin America iPSC Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 50. Latin America iPSC Therapy Market Size by Country (US$ Million), 2021–2026
Table 51. Latin America iPSC Therapy Market Size by Country (US$ Million), 2027–2032
Table 52. Middle East & Africa iPSC Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 53. Middle East & Africa iPSC Therapy Market Size by Country (US$ Million), 2021–2026
Table 54. Middle East & Africa iPSC Therapy Market Size by Country (US$ Million), 2027–2032
Table 55. Fujifilm Company Details
Table 56. Fujifilm Business Overview
Table 57. Fujifilm iPSC Therapy Product
Table 58. Fujifilm Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 59. Fujifilm Recent Development
Table 60. Ncardia Company Details
Table 61. Ncardia Business Overview
Table 62. Ncardia iPSC Therapy Product
Table 63. Ncardia Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 64. Ncardia Recent Development
Table 65. Sumitomo Dainippon Pharma Company Details
Table 66. Sumitomo Dainippon Pharma Business Overview
Table 67. Sumitomo Dainippon Pharma iPSC Therapy Product
Table 68. Sumitomo Dainippon Pharma Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 69. Sumitomo Dainippon Pharma Recent Development
Table 70. Astellas Pharma Inc Company Details
Table 71. Astellas Pharma Inc Business Overview
Table 72. Astellas Pharma Inc iPSC Therapy Product
Table 73. Astellas Pharma Inc Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 74. Astellas Pharma Inc Recent Development
Table 75. Fate Therapeutics, Inc Company Details
Table 76. Fate Therapeutics, Inc Business Overview
Table 77. Fate Therapeutics, Inc iPSC Therapy Product
Table 78. Fate Therapeutics, Inc Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 79. Fate Therapeutics, Inc Recent Development
Table 80. Pluricell Biotech Company Details
Table 81. Pluricell Biotech Business Overview
Table 82. Pluricell Biotech iPSC Therapy Product
Table 83. Pluricell Biotech Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 84. Pluricell Biotech Recent Development
Table 85. Cell Inspire Biotechnology Company Details
Table 86. Cell Inspire Biotechnology Business Overview
Table 87. Cell Inspire Biotechnology iPSC Therapy Product
Table 88. Cell Inspire Biotechnology Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 89. Cell Inspire Biotechnology Recent Development
Table 90. ReproCELL Company Details
Table 91. ReproCELL Business Overview
Table 92. ReproCELL iPSC Therapy Product
Table 93. ReproCELL Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 94. ReproCELL Recent Development
Table 95. Thermo Fisher Scientific Company Details
Table 96. Thermo Fisher Scientific Business Overview
Table 97. Thermo Fisher Scientific iPSC Therapy Product
Table 98. Thermo Fisher Scientific Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 99. Thermo Fisher Scientific Recent Development
Table 100. Sartorius Company Details
Table 101. Sartorius Business Overview
Table 102. Sartorius iPSC Therapy Product
Table 103. Sartorius Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 104. Sartorius Recent Development
Table 105. Bio-techne Company Details
Table 106. Bio-techne Business Overview
Table 107. Bio-techne iPSC Therapy Product
Table 108. Bio-techne Revenue in iPSC Therapy Business (US$ Million), 2021–2026
Table 109. Bio-techne Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
Table 113. Authors List of This Report
List of Figures
Figure 1. iPSC Therapy Picture
Figure 2. Global iPSC Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global iPSC Therapy Market Share by Type: 2025 vs 2032
Figure 4. Human iPSCs Features
Figure 5. Mouse iPSCs Features
Figure 6. Global iPSC Therapy Market Size Comparison by End User (US$ Million), 2021–2032
Figure 7. Hospitals Features
Figure 8. Biotech Firms Features
Figure 9. Research Institutes Features
Figure 10. Global iPSC Therapy Market Size Comparison by Cell Type (US$ Million), 2021–2032
Figure 11. Neural Cells Features
Figure 12. Cardiac Cells Features
Figure 13. Retinal Cells Features
Figure 14. Immune Cells Features
Figure 15. Global iPSC Therapy Market Size by Application (US$ Million), 2021–2032
Figure 16. Global iPSC Therapy Market Share by Application: 2025 vs 2032
Figure 17. Academic Research Case Studies
Figure 18. Drug Development and Discovery Case Studies
Figure 19. Toxicity Screening Case Studies
Figure 20. Regenerative Medicine Case Studies
Figure 21. Others Case Studies
Figure 22. iPSC Therapy Report Years Considered
Figure 23. Global iPSC Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 24. Global iPSC Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global iPSC Therapy Market Share by Region: 2025 vs 2032
Figure 26. Global iPSC Therapy Market Share by Players in 2025
Figure 27. Global iPSC Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. The Top 10 and 5 Players Market Share by iPSC Therapy Revenue in 2025
Figure 29. North America iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. North America iPSC Therapy Market Share by Country (2021–2032)
Figure 31. United States iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Canada iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Europe iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Europe iPSC Therapy Market Share by Country (2021–2032)
Figure 35. Germany iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. France iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. U.K. iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Italy iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Russia iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Ireland iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Asia-Pacific iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Asia-Pacific iPSC Therapy Market Share by Region (2021–2032)
Figure 43. China iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Japan iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. South Korea iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Southeast Asia iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. India iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Australia & New Zealand iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Latin America iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Latin America iPSC Therapy Market Share by Country (2021–2032)
Figure 51. Mexico iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Brazil iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Middle East & Africa iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Middle East & Africa iPSC Therapy Market Share by Country (2021–2032)
Figure 55. Israel iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Saudi Arabia iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. UAE iPSC Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Fujifilm Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 59. Ncardia Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 60. Sumitomo Dainippon Pharma Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 61. Astellas Pharma Inc Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 62. Fate Therapeutics, Inc Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 63. Pluricell Biotech Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 64. Cell Inspire Biotechnology Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 65. ReproCELL Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 66. Thermo Fisher Scientific Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 67. Sartorius Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 68. Bio-techne Revenue Growth Rate in iPSC Therapy Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
